Company Insider: President and CEO of $AVGO unloads 40,000 shares

The recent sale of 40,000 shares of $AVGO by Hock E Tan, the President and CEO of the company, has caught the attention of investors and analysts alike. The transaction, which took place on 06-26-2025, amounted to an estimated $10,731,720. This sale represented about 7.7% of Tan’s holdings of this particular class of stock, leaving him with 482,836 shares of $AVGO.

Insider trading activity within $AVGO has been quite active in the past six months, with insiders conducting trades on the open market 35 times. Out of these trades, 0 were purchases, and 35 were sales. Notable figures within the company, such as Henry Samueli, Mark David Brazeal, Kirsten M. Spears, and Charlie B Kawwas, have all engaged in selling shares of $AVGO within this period. These transactions have ranged in value and volume, showcasing the diverse trading activities of insiders.

On the institutional investor front, 1,952 firms have added shares of $AVGO to their portfolios, while 1,829 have decreased their positions in the most recent quarter. Major moves were made by institutions such as Capital World Investors, Capital International Investors, Price T Rowe Associates Inc /MD/, Norges Bank, Wellington Management Group LLP, JPMorgan Chase & Co, and Amundi, who either added or removed significant numbers of shares from their holdings.

Members of Congress have also been active in trading $AVGO stock, with a total of 30 trades in the past six months. These trades have been a mix of purchases and sales, with representatives like David Taylor, Jefferson Shreve, Bruce Westerman, Dan Newhouse, Kelly Morrison, John Boozman, Robert Bresnahan, Byron Donalds, Josh Gottheimer, Jared Moskowitz, Gilbert Ray Cisneros Jr., Julie Johnson, and James Comer engaging in various transactions involving $AVGO.

Analyst ratings for $AVGO have been predominantly positive, with 8 firms issuing buy ratings on the stock. Recent reports from firms such as HSBC, Cowen & Co., Evercore ISI, Citigroup, Barclays, Daiwa, and Morgan Stanley have all backed the stock with favorable ratings. Price targets for $AVGO have also been set by analysts, with a median target of $258.5. Notable price targets from analysts include HSBC’s target of $400.0, Truist Financial’s target of $295.0, Barclays’ target of $215.0, Daiwa’s target of $225.0, and Mizuho Securities’ target of $250.0.

As always, it is crucial to conduct thorough research and due diligence before making any investment decisions. Investors are advised to refer to Quiver Quantitative’s disclaimers for further information.